Delivery Order SPE2DR25D3111-SPE2DR26FF3PL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,315.72 to AmerisourceBergen Drug Corp for Simbrinza 1%-0.2% eye drops (8ml) on December 9, 2025, with an ultimate completion date of December 10, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.60 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Simbrinza 1%-0.2% ophthalmic drops in an 8ml container. This competitively awarded, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $8,536.43 to AmerisourceBergen Drug Corp for the supply of Simbrinza 1%-0.2% eye drops (8mL) on September 24, 2025, with completion expected by September 25, 2025. This firm fixed-price, competitively awarded contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $1,901.52 delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Simbrinza 1%-0.2% eye drops in 8ml quantities. This is a firm fixed-price, non-set-aside contract with performance through October 29, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,759.58 firm fixed price contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a completion date of April 26, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.64 Firm Fixed Price Delivery Order is for the supply of SIMBRINZA 1%-0.2% eye drops, 8 ml, and has an ultimate completion date of June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,053.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of SIMBRINZA 1%-0.2% eye drops. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support...
- This is a firm fixed-price delivery order awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,798.88 contract is for the provision of SIMBRINZA 1%-0.2% eye drops in 8 ml bottles, with a period of performance through March 12, 2024. No set-aside designation was used for this award. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,117.10, is for the procurement of Simbrinza 1%-0.2% eye drops, a medical product used in the treatment of various eye conditions. The contract has an ultimate completion date of April 19, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite...
- Defense Logistics Agency Troop Support Medical awarded a $1,234.56 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for SIMBRINZA 1%-0.2% eye drop medication. The contract has no set-aside designation and requires delivery to a location in Conshohocken, Pennsylvania by October 13, 2023. As the Defense Logistics Agency supports the medical readiness of armed forces worldwide, this contract will likely supply needed eye drop...
- SPE2DR25D3111Indefinite Delivery Contract
- SPE2DR25D3111-SPE2DR26FF3PLDelivery Order
The Defense Logistics Agency awarded a $1,436.71 delivery order to AmerisourceBergen Drug Corp for Simbrinza 1%-0.2% eye drops (8 ml) under a firm fixed price contract. This non-set-aside award, issued on December 11, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 12, 2025. This delivery order is issued under AmerisourceBergen's comprehensive $999.99 billion IDC (SPE2DX) with DLA Troop Support Medical, valued through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems worldwide. The Simbrinza ophthalmic medication fulfills medical supply requirements for Defense Health Agency and other federal healthcare customers through this flexible contracting vehicle, which enables rapid fulfillment of pharmaceutical needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 12/10/25 |